Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
12 July 2021 - 393
In vitro activity of dalbavancin against glycopeptide-resistant Enterococcus faecium and coagulase-negative staphylococci recovered from patients in Germany
Michael Kresken, M. Kresken (1, 2), I. Klare (3), T.A. Wichelhaus (4), E. Wohlfarth (1), G. Werner (3)
11 July 2021 - 4821
The evolution of carbapenem resistance determinants and major epidemiological lineages among carbapenem-resistant Acinetobacter baumannii isolates in Germany, 2010-2019
Esther Wohlfarth, E. Wohlfarth (1), M. Kresken (1, 2), P. Higgins (3, 4), D. Stefanik (3), J. Wille (3, B. Körber-Irrgang (1, 5), H. Seifert (3
09 July 2021 - 443
Multidrug-resistance in Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa and susceptibility to four last resort antimicrobials, Germany
Michael Kresken, M. Kresken (1, 2), E. Wohlfarth (1), T.A. Wichelhaus (3), S.G. Gatermann (4), H. Seifert (5)
09 July 2021 - 4385
Determination of a dalbavancin epidemiological cut-off value (ECOFF) for Enterococcus faecium
Robert Weber, R. Weber (1), C. Fleige (1), F. Layer (1), B. Neumann (1), M. Kresken (2), G. Werner (2, 1)
09 July 2021 - 395
In vitro activity of ceftolozane/tazobactam against Enterobacterales and Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia in Germany
Michael Kresken, M. Kresken (1, 2), B. Körber-Irrgang (1), M. Korte-Berwanger (3, 4), N. Pfennigwerth (3), S.G. Gatermann (3), E. Wohlfarth (1), H. Seifert (5)
09 July 2021 - 2164
Genome-based characterisation of colistin-resistant Escherichia coli isolates from human patients and livestock products in Germany
Wiebke Rackwitz, W. Rackwitz (1), B. Neumann (1), N. Pfennigwerth (2), K.P. Hunfeld (3), M. Kresken (4), R. Leistner (5), M. Probst-Kepper (6), S. Fuchs (7), G. Werner (1), Y. Pfeifer (1)
22 April 2018 - P1072
Occurrence of carbapenemase-producing strains among Enterobacteriaceae urine isolates in three geographic areas in Germany
Michael Kresken, M. Kresken, B. Körber-Irrgang, G. Hischebeth, A. Hoerauf, N. von Allmen, M. Hogardt, T. Wichelhaus, N. Pfennigwerth, S. Gatermann
21 April 2018 - O0124
Dissemination of carbapenem-resistant, carbapenemase non-producing and carbapenemase-producing Pseudomonas aeruginosa in Germany
Sally C.Y. Wong, M. Kresken, B. Körber-Irrgang, M. Korte-Berwanger, N. Pfennigwerth, S. Gatermann
11 April 2016 - P1314
In vitro activity of ceftolozane-tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates recovered from hospitalized patients in Germany
Michael Kresken, Tsuji Masakatsu, Kresken Michael, M. Kresken, B. Körber-Irrgang, H. Seifert, G. Study Group
11 April 2016 - EP0077
Multidrug resistance to oral antibiotics in Escherichia coli urine isolates from outpatients in Germany and in vitro activity of nitroxoline: results of the PEG 2013 study
Michael Kresken, Kresken Michael, M. Kresken, B. Körber-Irrgang, D. Hafner, W. of the Paul-Ehrlich-Society for Chemotherapy
10 April 2016 - P0615
Comparative susceptibilities of Clostridium difficile isolates to fidaxomicin obtained from community and hospitalized patients: results of the PEG 2013 study
Barbara Körber-Irrgang, Körber-Irrgang Barbara, Mannino Raphael, B. Körber-Irrgang, L. von Müller, J. Westenberger, D. Hafner, M. Kresken, W. of the Paul-Ehrlich-Society for Chemotherapy
09 April 2016 - P0326
Prevalence of multidrug resistance among bacterial pathogens obtained from patients in hospitals and the role of tigecycline: results of the PEG 2013 study
Michael Kresken, Ercibengoa Maria, Kresken Michael, M. Kresken, B. Körber-Irrgang, D. Hafner, M. Kaase, F. Layer, I. Klare, G. Werner, H. Seifert, W. of the Paul-Ehrlich-Society for Chemotherapy
29 April 2013 - P1718
Frontline identification of bacterial isolates using the MALDI Biotyper-system during a resistance surveillance study in a central European area, 2010
Michael Kresken, B. Körber-Irrgang*, M. Kresken (Rheinbach, DE)
28 April 2013 - P1531
Susceptibilities of Gram-negative pathogens from hospitalised patients to colistin and fosfomycin in Germany, 2010
Michael Kresken, M. Kresken*, B. Körber-Irrgang, D. Hafner on behalf of the Working Party
28 April 2013 - P1557
Phenotypic detection of carbapenemase-producing Gram-negative bacteria using the MICRONAUT-S system for antimicrobial susceptibility testing
Michael Kresken, B. Körber-Irrgang*, H. Schedletzky, M. Kaase, M. Kresken (Rheinbach, Bornheim, Bochum, DE)
28 April 2013 - P1618
In vitro activity of ceftaroline against Gram-positive and Gram-negative pathogens obtained from hospitalised, skin-infected patients in Germany, 2011-2012
Michael Kresken, M. Kresken*, B. Körber-Irrgang on behalf of the German Ceftarolin Study Group
28 April 2013 - O345
Relationship between carbapenem consumption and the occurrence of carbapenem-resistance amongst Enterobacteriaceae isolates causing healthcare-associated infections: Germany, 1995-2010
Michael Kresken, M. Kresken*, B. Körber-Irrgang, D. Hafner, M. Kaase on behalf of the Working Party
28 April 2013 - O311
In vitro activity of nitroxoline against urine isolates of Escherichia coli from the community: results of a German multicentre study
Michael Kresken, M. Kresken*, B. Körber-Irrgang on behalf of the Working Party Antimicrobial Resistance of the Paul Ehrlich Society of Chemotherapy
28 April 2013 - P1522
In vitro antibacterial activity of tigecycline against 434 multidrug-resistant pathogens in Germany and a central European area, 2010
Michael Kresken, B. Körber-Irrgang*, M. Kresken on behalf of the Working Party Antimicrobial Resistance of the Paul Ehrlich Society of Chemotherapy
27 April 2013 - P985
Epidemiology of Candida species from sterile specimens in Germany and susceptibility to antifungal agents in vitro using the EUCAST method
Michael Kresken, M. Kresken*, B. Körber-Irrgang, C. Lass-Flörl, A.H. Groll on behalf of the Working Party Antimicrobial Resistance of the Paul Ehrlich Society of Chemotherapy
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.